Skip to main content
ARAY
NASDAQ Industrial Applications And Services

Accuray Receives Nasdaq Delisting Notice for Failing Minimum Bid Price Rule

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.62
Mkt Cap
$70.272M
52W Low
$0.54
52W High
$2.95
52W Position info
15% above low
Off High info
79% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

ARAY is trading near its 52-week low of $0.54 (15% above the low).

Summary

Accuray Inc. received a notice from Nasdaq regarding non-compliance with the minimum $1.00 bid price rule, initiating a 180-day compliance period to avoid potential delisting.


Key Events · Legal and Risk Events · ARAY

  • Nasdaq Delisting Notice Received

    On February 2, 2026, Accuray Inc. received a notice from Nasdaq for failing to maintain a minimum bid price of $1.00 per share over the last 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2).

  • 180-Day Compliance Period Initiated

    The company has been granted a 180-calendar day period, until August 3, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for a minimum of ten consecutive business days.

  • Potential for Reverse Stock Split

    If compliance is not met within the initial period, the company may be eligible for an additional 180 days by transferring to the Nasdaq Capital Market, potentially requiring a reverse stock split to cure the deficiency.

  • Follows Recent Negative Earnings

    This delisting notice comes just two days after the company reported a significant Q2 net loss and negative Adjusted EBITDA on February 4, 2026, further highlighting its financial struggles.


Analysis · ARAY · Industrial Applications And Services

Accuray Inc. has received a notice from Nasdaq indicating non-compliance with the minimum $1.00 bid price rule, a critical development that underscores the company's ongoing financial challenges. This delisting notice follows closely on the heels of the company's recent Q2 earnings report on February 4, 2026, which disclosed a significant net loss and negative Adjusted EBITDA, along with reduced full-year guidance. The persistent low stock price, currently at $0.62, reflects deep investor concerns about the company's financial health and operational performance. Failure to regain compliance within the 180-day period could lead to the stock being delisted from Nasdaq, severely impacting its liquidity and investor confidence. While the company is evaluating options, including a potential reverse stock split, the path to regaining compliance appears challenging given its recent performance and the need for a sustained price recovery.

At the time of this filing, ARAY was trading at $0.62 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $70.3M. The 52-week trading range was $0.54 to $2.95. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ARAY - Latest Insights

ARAY
Jun 04, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3655
Real-time Price: $0.2362 info
Change: -$0.1293 (-35%) info
Market Cap: $28.361M info
ARAY
May 22, 2026, 3:57 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $0.3077
Real-time Price: $0.2362 info
Change: -$0.0715 (-23%) info
Market Cap: $28.361M info
ARAY
May 06, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.4105
Real-time Price: $0.2362 info
Change: -$0.1743 (-42%) info
Market Cap: $28.361M info
ARAY
May 06, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.4724
Real-time Price: $0.2362 info
Change: -$0.2362 (-50%) info
Market Cap: $28.361M info
ARAY
Apr 28, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.4455
Real-time Price: $0.2362 info
Change: -$0.2093 (-47%) info
Market Cap: $28.361M info